This compound is a nitrosamine impurity associated with the pharmaceutical compound sitagliptin. It is primarily recognized as a process-related impurity in pharmaceutical manufacturing and quality control.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2892260-32-9
2-Amino-4'-chlorobenzophenone
pharmaceutical intermediate
N-Benzyltropinone
pharmaceutical intermediate
2-(3,5-Bis(trifluoromethyl)phenyl)-2-methylpropionic acid
pharmaceutical intermediate
Ethyl L-methionate hydrochloride
pharmaceutical intermediate
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
pharmaceutical intermediate
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
pharmaceutical intermediate
7-nitroso-3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine
HPLUAAVIJHAQQZ-UHFFFAOYSA-N
C1CN2C(=NN=C2C(F)(F)F)CN1N=O